Speaking at 8th Regenerative Medicine EXPO Tokyo

On May 21, 2026 (Thursday), CEO Shinichi Sakurada, Co-Founder and President, will present at Session RM-S4 "The New Era of Cell Manufacturing Transformed by AI" at the 8th Regenerative Medicine EXPO, part of INTERPHEX Week Tokyo 2026, held at Makuhari Messe.

The presentation will cover how regenerative medicine is entering a transformative phase from research to social implementation. Through our cardiac regeneration initiatives, we will introduce the development of medical manufacturing processes that integrate AI, digital twin, and 3D bioprinting technologies.

Additionally, we will discuss the challenges of establishing medicine as a "manufacturing" industry and the future vision of next-generation medical manufacturing.

We look forward to seeing you there.